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C
hest pain may be associated with 
coronary arteries that appear 
“normal.” Normal is deﬁ  ned 
here as no visible disease or luminal 
irregularities (less than 50%) as judged 
visually at coronary angiography. 
Normal angiography in patients with 
chest pain is ﬁ  ve times more common 
in women than in men [1]. Among 
patients with chest pain and normal 
angiography, an unknown number 
are suffering from cardiac pain of 
ischemic origin. Uncertainty is often 
difﬁ  cult to allay, for medical attendants 
as well as for patients, resulting in 
perpetuation of symptoms, difﬁ  culties 
in management, and establishment of 
risk of subsequent coronary events [2]. 
In this article, we discuss how to stratify 
risk in patients with chest pain and a 
normal coronary angiogram. We based 
our article on a literature review, using 
the key words “angina with normal 
angiography,” “angina with normal 
coronary arteries,” “non-obstructive 
coronary disease,” or “chest pain of 
non-cardiac origin,” plus “[a]etiology,” 
“pathophysiology,” “diagnosis,” 
“classiﬁ  cation,” “prognosis,” or 
“therapy.” A longer, more detailed 
version of this paper is found in the 
supplementary ﬁ  le S1.
Deﬁ  nition
Over the past ten years, many terms 
have been proposed to label patients 
suffering chest pain due to myocardial 
ischemia despite normal coronary 
angiography, including syndrome 
X [3], microvascular angina [4], 
and non-atherosclerotic myocardial 
ischemia [5]. The term syndrome X 
refers only to patients showing ST-
segment depression on an exercise 
electrocardiogram (ECG) with 
completely smooth coronary arteries 
at angiography. More recently it has 
come to be used also for the metabolic 
syndrome, comprising hypertension, 
insulin resistance, elevated 
triglycerides, low levels of high-density-
lipoproteins, and obesity. The term 
microvascular angina may have outlived 
its usefulness, because patients with 
chest pain and normal angiography 
often exhibit a disorder not only of 
the coronary microcirculation, but 
also of the entire coronary artery and 
peripheral circulation [6,7].
Mechanisms
The idea that some forms of ischemic 
heart disease may be caused by 
abnormalities of the microcirculatory 
vessels is not new. This idea was 
proposed 16 years ago as a cause of 
angina pectoris [4]. Although the 
importance of microcirculation for the 
regulation of coronary blood ﬂ  ow has 
become clearer, pathophysiological 
explanations of the disease process are 
still poorly understood.
Vascular dysfunction. Abnormality 
of both endothelium-dependent and 
independent vasodilatation due to early 
atheroma may be a cause of vascular 
dysfunction [7–11].
A normally functioning vascular 
endothelium is required for 
appropriate dilatation of arteries 
during exercise [12]. Endothelial 
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dysfunction could underlie a 
nonspeciﬁ  c enhancement of the 
response to all vasoconstrictor stimuli 
[9]. Impairment of endothelium-
  dependent dilatation shifts a net dilator 
response to sympathetic stimulation to 
a net constrictor response [10].
“Occult” atherosclerosis. Recent 
pathophysiological studies show that 
the current concept of myocardial 
ischemia induced by epicardial 
coronary functional or ﬁ  xed luminal 
narrowing should be renewed. 
Acute coronary syndromes often 
result from disruption of modestly 
stenotic plaques, not detectable by 
angiography, but only by intravascular 
ultrasound [13–15]. Plaque rupture 
and erosion often leads to thrombotic 
complications [14], or occasionally 
plaques may rupture and debris may 
be washed downstream, leading to 
peripheral coronary microembolization 
often associated with rhythm 
abnormalities [16]. Disturbed 
microvascular integrity could therefore 
be due to “hidden” epicardial 
atherosclerosis and its complications.
Prognosis
The prognosis of patients with chest 
pain and normal or near normal 
coronary arteries at angiography is not 
as benign as reported by preliminary 
cohort studies. Many such patients 
are at an increased risk of myocardial 
infarction and cardiac death. In 
fact, 2% of patients—men and 
women—with unstable angina and 
non-ST-segment elevation (and normal 
or near normal coronary arteries at 
angiography) die within one year of 
their admission [17]. 
The risk is not invariably high 
and the Thrombolysis in Myocardial 
Infarction (TIMI) Risk Score helps 
to estimate risk. The rate of death or 
non-fatal myocardial infarction climbs 
from 0.6% in patients with a TIMI 
score of 1, to 4.1% in those with a 
score of 4 or more. Adverse outcomes 
may also occur in less acute clinical 
conditions. The combined risk of 
death, myocardial infarction, stroke, 
and heart failure is over 2% per year 
in women with a history of chronic 
chest pain symptoms persisting more 
than one year [18]. The population 
is heterogeneous and the presence 
of coronary vascular dysfunction may 
predict the likelihood of patients 
developing coronary events.
Coronary Vascular Dysfunction
Coronary vascular dysfunction due to 
abnormal endothelium-dependent 
coronary vasodilatation is predictive 
of adverse outcomes [7,8,19–21]. 
Conversely, impaired endothelial  -
independent vasodilatation predicts 
favorable outcomes [19]. The reason 
for this discrepancy is not known. 
One might hypothesize that a blunted 
response to exogenous nitric oxide 
donors (coronary endothelial-
independent vasodilatation) might 
simply reﬂ  ect the presence of 
atherosclerosis, leading to increased 
stiffness of the vessel wall [20]. 
Conversely, endothelial dysfunction 
and atherosclerosis, although causally 
related, are distinct problems and may 
exist separately. Coronary endothelial 
vasoreactivity may indeed represent an 
index that combines information about 
the underlying atherosclerotic process 
and the overall stress imposed by risk 
factors on the arterial wall.
Endothelial function. Coronary 
endothelial dysfunction in patients 
with signiﬁ  cant coronary artery 
disease (CAD) provides prognostic 
value independent of the traditional 
cardiovascular risk factor assessment 
[22]. Recent investigations addressed 
this issue in patients with chest pain 
and normal coronary angiography, 
and showed that 30% of patients with 
chest pain and severe endothelial 
dysfunction, as assessed by 
intracoronary acetylcholine testing, 
developed angiographically visible 
atherosclerosis during a ten-year follow-
up [8].
Other studies evaluated patients 
with normal or near normal coronary 
angiography for a mean follow-up of 
four to six years [7,19–21]. Endpoints 
of analysis were cardiovascular death, 
acute myocardial infarction, unstable 
angina pectoris, and acute ischemic 
stroke. Acute vascular events occurred 
in 4.5% of patients. When patients 
were divided into two groups with 
either normal or abnormal endothelial 
function, the event rate of patients with 
endothelial dysfunction increased up 
to 14%.
Clinical Decision Making
Nearly 4 million cardiac 
catheterizations are performed 
annually in United States hospitals 
alone, with one in ten discharges 
having undergone coronary 
arteriography [23]. More than 20% 
of patients aged 45–79 years admitted 
to hospital receive diagnostic cardiac 
catheterization [23]. More than 50% 
of women who are referred for cardiac 
catheterization because of chest pain 
show non-obstructive coronary lesions 
or smooth coronary arteries. [24]. Most 
of these patients have no diagnosis of 
angina at the time of discharge.
Epidemiological studies show that 
undiagnosed angina is costly in terms 
of mortality, morbidity, and health-care 
utilization [25]. In one study, over 65% 
of patients were re-hospitalized for 
chest pain during an 11-year follow-up 
and still remained without a diagnosis 
of angina [25]. Among those with an 
abnormal ECG result, the absolute 
risk of non-fatal myocardial infarction 
was similar in those with and without 
a diagnosis of angina (16% versus 
15%). Also, compared with apparently 
healthy people, those with undiagnosed 
and diagnosed angina had a 2.4 and 
3.2 times greater risk, respectively, 
of impaired physical functioning 
[25]. These ﬁ  ndings underscore the 
importance of greater vigilance in 
identifying the causes of angina in 
patients with normal angiography
Symptoms and quality of life. Chest 
pain is the most common symptom of 
coronary atherosclerosis prompting 
patients to seek medical attention. 
Patients with normal or near normal 
coronary arteries may present with stable 
or unstable symptoms [8,17,18,26]. 
At one extreme are patients in whom 
angina develops every time the workload 
of the heart is increased beyond a fairly 
ﬁ  xed threshold; at the other extreme 
are patients who are not necessarily 
restricted in their physical activity by 
angina, but suffer rest pain without 
an obvious cause. Both women and 
men most commonly report typical 
angina [8,17]. Along with severe and 
often unpredictable symptoms, chest 
pain is often associated with increased 
psychological morbidity, debilitating 
symptoms, and a poor quality of life 
[27–29]
In clinical practice, symptoms 
in most of these patients are often 
indistinguishable from those with 
obstructive CAD. More information 
and additional testing is needed. It is 
always important to establish whether 
or not myocardial ischemia is present.
Noninvasive testing. Use of imaging 
rather than non-imaging stress testing 
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may be helpful in the identiﬁ  cation 
of microvascular ﬂ  ow obstruction. 
Magnetic resonance imaging and 
gated-single photon emission 
computed tomography (SPECT) show 
a substantial overlap in detection of 
adequate or inadequate ﬂ  ow reserve 
patterns [30]. In patients with a normal 
resting ECG, exercise stress myocardial 
perfusion SPECT yields additional 
prognostic value over clinical, historical, 
and exercise treadmill test data for the 
prediction of coronary events [31]. 
SPECT abnormality is predictive of both 
cardiac death and myocardial infarction 
in patients with obstructive and non-
obstructive CAD [32]. Perfusion 
imaging, unlike angiography, closely 
correlates with ﬂ  ow reserve and reﬂ  ects 
function of the epicardial conduit 
arteries as well as normal capacity of the 
resistance vessels [31].
A growing number of centers offer 
sophisticated cardiac diagnostic tests 
to aid diagnosis and management of 
patients with ischemic heart disease. 
These tests include magnetic resonance 
imaging, high frequency transthoracic 
Doppler harmonic echocardiography, 
and transesophageal echocardiography 
with Doppler imaging. [30,33,34]
In clinical practice, ischemia with 
standard SPECT testing identiﬁ  es 
symptomatic patients at relatively high 
risk of a subsequent cardiac event.
Routine coronary angiography. 
Data analysis of patients undergoing 
their ﬁ  rst coronary angiography over a 
three-year period showed that 32% had 
entirely normal coronary angiograms 
and an additional 15% had less than a 
50% stenosis in any of the major vessels 
[35]. The frequency of non-obstructive 
CAD is higher in black patients and in 
women. Chronic stable angina is the 
most common clinical presentation 
in patients without obstructive CAD. 
Many of these patients do not have 
angiographically visible plaques, but 
they have coronary disease.
In clinical practice, new effective 
technologies may provide better 
understanding of the mechanisms that 
account for chest pain in patients with 
normal or near normal angiography.
New invasive technologies. Sensor-
tipped guidewires have enabled 
cardiologists to identify physiological 
measures such as absolute coronary 
ﬂ  ow reserve, relative coronary ﬂ  ow 
reserve, and pressure-derived fractional 
ﬂ  ow reserve. The most frequently 
used measure is absolute coronary 
ﬂ  ow reserve. Intravascular ultrasound 
(IVUS) is a relatively new modality 
for assessment of atherosclerotic 
disease burden. IVUS showed that 
atherosclerotic disease is diffuse 
and involves the entire arterial tree, 
including multiple plaques that are not 
associated with vessel narrowing.
Early signs of atherosclerosis can 
be detected by IVUS. This may have 
important therapeutic and prognostic 
implications [36].
Endothelial function testing. Over 
the past several years, sophisticated 
techniques have evolved to measure 
endothelium  -dependent vasodilatation 
in the brachial and coronary arteries 
[37]. Peripheral endothelial function 
testing through measurements of ﬂ  ow-
mediated vasodilatation is attractive 
because it is non-invasive and allows 
repeated measurements. Coronary 
artery endothelial function is most 
commonly assessed by intracoronary 
infusion of acetylcholine, which, acting 
via muscarinic receptors on endothelial 
cells, causes release of nitric oxide and 
coronary artery dilation [6,7,11,12]. 
Reduced vasodilatory response of the 
coronary microcirculation or paradoxical 
vasoconstriction of the epicardial 
vessels is a sign of coronary endothelial 
dysfunction. The relationship between 
peripheral and coronary endothelial 
function is still under scrutiny.
Intracoronary acetylcholine testing 
may be used for patients who, 
during angiography, turn out not to 
have obstructed coronary vessels. 
Endothelial function measurement 
by peripheral testing may be a 
useful surrogate to reduce costs, 
inconvenience, and risks associated 
with invasive techniques during medical 
follow-up.
Approach to Management 
of Individual Patients
There are currently no critical pathways 
speciﬁ  cally developed for patients with 
chest pain and normal angiograms. 
So far, physicians apply (in varying 
proportions) pathophysiologic 
reasoning, personal clinical experience, 
and published research in the 
development of their own clinical 
approaches. Treatment objectives 
include symptom relief and risk factor 
identiﬁ  cation and management with 
the objective of reducing progression 
in the underlying disease process with 
enhancement of event-free survival.
Symptom relief. At present, all 
patients with chronic, stable ischemic 
heart disease should receive long-
term treatment with beta-blockers to 
control angina even if they have normal 
or near normal coronary arteries at 
angiography [38]. Assuming that the 
patient has no evidence of myocardial 
ischemia and/or vascular dysfunction 
on image stress testing, they can be 
discharged on imipramine in an 
attempt to manage chest pain. Patients 
without evidence of a cardiac etiology 
may require referral for evaluation of 
noncardiac causes of chest pain.
Risk factor control and enhancement 
of event-free survival. Clinical 
guidelines recommend managing all 
patients with acute coronary syndromes 
with a standard set of therapies, 
independent of what coronary 
anatomy looks like [39]. Chronic stable 
symptoms may require a more selective 
intervention. Therapy with statins, and 
perhaps angiotensin-converting enzyme 
inhibitors, should be used for patients 
with evidence of coronary endothelial 
dysfunction and/or atherosclerotic 
plaques within the arterial wall detected 
by IVUS [38,40].
A negative angiographic test cannot 
alleviate the call for intensive lifestyle 
changes in these patients. The medical 
community should become increasingly 
aware that atherosclerosis poses a 
serious health risk even in its mild 
form. It is important to understand that 
the presence of coronary endothelial 
dysfunction and/or atherosclerotic 
plaques within the arterial wall is 
not normal and deserves medical 
intervention.
A Call for Clinical Trials
We recommend the development of 
large-scale prospective collaborative 
clinical trials as well as retrospective 
analyses of already completed trials, 
in which the results of angiography 
may be available in at least a portion 
of patients. Large numbers of 
patients will need to be studied, 
since relatively low-risk patients will 
be included. These studies require 
considerable communication among 
all parties: researchers, physicians, 
hospital administrators, patient 
groups, and policy planners. This 
communication can only be realized 
by close collaboration between 
important scientiﬁ  c institutions playing 
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a prominent role in research funding 
and program development. A call to 
action for risk assessment strategies in 
this area is warranted.  
Supplementary Information
Text S1. Longer, more detailed version of 
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Found at doi:10.1371/journal.
pmed.0040012.sd001 (119 KB DOC).
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